214 related articles for article (PubMed ID: 22519914)
1. The need for worldwide policy and action plans for rare diseases.
Forman J; Taruscio D; Llera VA; Barrera LA; Coté TR; Edfjäll C; Gavhed D; Haffner ME; Nishimura Y; Posada M; Tambuyzer E; Groft SC; Henter JI;
Acta Paediatr; 2012 Aug; 101(8):805-7. PubMed ID: 22519914
[TBL] [Abstract][Full Text] [Related]
2. The European Union Policy in the Field of Rare Diseases.
Moliner AM; Waligora J
Adv Exp Med Biol; 2017; 1031():561-587. PubMed ID: 29214592
[TBL] [Abstract][Full Text] [Related]
3. Review of 11 national policies for rare diseases in the context of key patient needs.
Dharssi S; Wong-Rieger D; Harold M; Terry S
Orphanet J Rare Dis; 2017 Mar; 12(1):63. PubMed ID: 28359278
[TBL] [Abstract][Full Text] [Related]
4. Drugs for rare diseases: mixed assessment in Europe.
Prescrire Int; 2007 Feb; 16(87):36-42. PubMed ID: 17323539
[TBL] [Abstract][Full Text] [Related]
5. Why we should care about ultra-rare disease.
Harari S
Eur Respir Rev; 2016 Jun; 25(140):101-3. PubMed ID: 27246584
[TBL] [Abstract][Full Text] [Related]
6. Legal assessment of current situation on orphan patients in Lithuania.
Spokiene I
Medicina (Kaunas); 2008; 44(8):571-6. PubMed ID: 18791333
[TBL] [Abstract][Full Text] [Related]
7. Access to information supporting availability of medicines for patients suffering from rare diseases looking for possible treatments: the EuOrphan Service.
Stakisaitis D; Spokiene I; Juskevicius J; Valuckas KP; Baiardi P
Medicina (Kaunas); 2007; 43(6):441-6. PubMed ID: 17637514
[TBL] [Abstract][Full Text] [Related]
8. National Organization for Rare Disorders (NORD): providing advocacy for people with rare disorders.
Putkowski S
NASN Sch Nurse; 2010 Jan; 25(1):38-41. PubMed ID: 20440954
[No Abstract] [Full Text] [Related]
9. Tackling rare diseases at European level: why do we need a harmonized framework?
Taruscio D; Trama A; Stefanov R
Folia Med (Plovdiv); 2007; 49(1-2):59-67. PubMed ID: 18018471
[TBL] [Abstract][Full Text] [Related]
10. Preparing for the Future of Rare Diseases.
Groft SC; Posada de la Paz M
Adv Exp Med Biol; 2017; 1031():641-648. PubMed ID: 29214596
[TBL] [Abstract][Full Text] [Related]
11. A fair share for the orphans: ethical guidelines for a fair distribution of resources within the bounds of the 10-year-old European Orphan Drug Regulation.
Pinxten W; Denier Y; Dooms M; Cassiman JJ; Dierickx K
J Med Ethics; 2012 Mar; 38(3):148-53. PubMed ID: 21947805
[TBL] [Abstract][Full Text] [Related]
12. Rare Diseases: Joining Mainstream Research and Treatment Based on Reliable Epidemiological Data.
Groft SC; Posada de la Paz M
Adv Exp Med Biol; 2017; 1031():3-21. PubMed ID: 29214563
[TBL] [Abstract][Full Text] [Related]
13. Policy framework for rare disease health disparities.
Holtzclaw Williams P
Policy Polit Nurs Pract; 2011 May; 12(2):114-8. PubMed ID: 21486874
[TBL] [Abstract][Full Text] [Related]
14. [Participant-funded clinical trials on rare diseases].
Dal-Ré R; Palau F; Guillén-Navarro E; Ayuso C
An Pediatr (Engl Ed); 2020 Oct; 93(4):267.e1-267.e9. PubMed ID: 32499195
[TBL] [Abstract][Full Text] [Related]
15. Brexit and rare diseases: big risk, bigger opportunity?
Hyry HI; Cox TM; Roos JC
Curr Med Res Opin; 2017 Apr; 33(4):783-784. PubMed ID: 28100081
[TBL] [Abstract][Full Text] [Related]
16. [Hungarian national plan and strategy for rare diseases].
Kosztolányi G
Orv Hetil; 2014 Mar; 155(9):325-8. PubMed ID: 24566695
[TBL] [Abstract][Full Text] [Related]
17. [The stakes of pre- and post-market authorization development and clinical assessment].
Schwebig A
Presse Med; 2012 May; 41 Suppl 1():S6-8. PubMed ID: 22483770
[No Abstract] [Full Text] [Related]
18. A cross-national comparative study of orphan drug policies in the United States, the European Union, and Japan: towards a made-in-China orphan drug policy.
Liu BC; He L; He G; He Y
J Public Health Policy; 2010 Dec; 31(4):407-20; discussion 420-1. PubMed ID: 21119648
[TBL] [Abstract][Full Text] [Related]
19. [RARE DISEASES DTC: DIAGNOSIS, TREATMENT AND CARE].
Mendlovic J; Barash H; Yardeni H; Banet-Levi Y; Yonath H; Raas-Rothschild A
Harefuah; 2016 Apr; 155(4):241-4, 253. PubMed ID: 27323543
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
